Varian Medical Systems, Inc. (VAR) EVP Sells $211,659.33 in Stock

Varian Medical Systems, Inc. (NYSE:VAR) EVP Kolleen T. Kennedy sold 2,021 shares of the business’s stock in a transaction that occurred on Thursday, July 13th. The stock was sold at an average price of $104.73, for a total transaction of $211,659.33. Following the sale, the executive vice president now directly owns 27,688 shares in the company, valued at $2,899,764.24. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Varian Medical Systems, Inc. (VAR) traded up 1.13% during midday trading on Friday, reaching $97.74. 812,205 shares of the company’s stock traded hands. The stock has a market cap of $8.97 billion, a PE ratio of 32.17 and a beta of 0.61. Varian Medical Systems, Inc. has a one year low of $75.20 and a one year high of $107.08. The stock’s 50 day moving average price is $101.70 and its 200-day moving average price is $93.39.

Varian Medical Systems (NYSE:VAR) last announced its quarterly earnings data on Wednesday, July 26th. The medical equipment provider reported $1.04 EPS for the quarter, topping the Zacks’ consensus estimate of $0.95 by $0.09. Varian Medical Systems had a return on equity of 24.70% and a net margin of 9.50%. The firm had revenue of $662.40 million for the quarter, compared to the consensus estimate of $663.86 million. During the same quarter last year, the business posted $1.00 earnings per share. The firm’s revenue was up 3.0% compared to the same quarter last year. Equities analysts predict that Varian Medical Systems, Inc. will post $3.94 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: “Varian Medical Systems, Inc. (VAR) EVP Sells $211,659.33 in Stock” was reported by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece on another domain, it was copied illegally and republished in violation of United States & international copyright & trademark law. The correct version of this piece can be accessed at https://www.com-unik.info/2017/08/11/kolleen-t-kennedy-sells-2021-shares-of-varian-medical-systems-inc-var-stock-updated-updated-updated.html.

A number of large investors have recently bought and sold shares of VAR. Vident Investment Advisory LLC increased its stake in Varian Medical Systems by 42.5% in the fourth quarter. Vident Investment Advisory LLC now owns 14,681 shares of the medical equipment provider’s stock worth $1,318,000 after buying an additional 4,381 shares in the last quarter. California Public Employees Retirement System increased its stake in Varian Medical Systems by 3.3% in the first quarter. California Public Employees Retirement System now owns 250,600 shares of the medical equipment provider’s stock worth $22,837,000 after buying an additional 8,100 shares in the last quarter. Hussman Strategic Advisors Inc. increased its stake in Varian Medical Systems by 9.0% in the first quarter. Hussman Strategic Advisors Inc. now owns 10,900 shares of the medical equipment provider’s stock worth $993,000 after buying an additional 900 shares in the last quarter. Bank of America Corp DE increased its stake in Varian Medical Systems by 4.6% in the first quarter. Bank of America Corp DE now owns 1,992,821 shares of the medical equipment provider’s stock worth $181,605,000 after buying an additional 87,522 shares in the last quarter. Finally, Teachers Advisors LLC increased its stake in Varian Medical Systems by 3.9% in the fourth quarter. Teachers Advisors LLC now owns 107,778 shares of the medical equipment provider’s stock worth $9,676,000 after buying an additional 4,000 shares in the last quarter. Institutional investors own 99.27% of the company’s stock.

A number of brokerages have recently issued reports on VAR. Zacks Investment Research lowered shares of Varian Medical Systems from a “buy” rating to a “hold” rating in a research note on Thursday, July 13th. BidaskClub upgraded shares of Varian Medical Systems from a “buy” rating to a “strong-buy” rating in a research note on Thursday, July 13th. Robert W. Baird reiterated a “neutral” rating and issued a $99.00 target price (up previously from $89.00) on shares of Varian Medical Systems in a research note on Friday, July 14th. Goldman Sachs Group, Inc. (The) assumed coverage on shares of Varian Medical Systems in a research note on Tuesday, May 16th. They issued a “neutral” rating and a $92.00 target price for the company. Finally, Jefferies Group LLC reiterated a “buy” rating on shares of Varian Medical Systems in a research note on Thursday, May 11th. Three research analysts have rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $96.28.

About Varian Medical Systems

Varian Medical Systems, Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Insider Buying and Selling by Quarter for Varian Medical Systems (NYSE:VAR)

What are top analysts saying about Varian Medical Systems Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Varian Medical Systems Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit